title: Lipoprotein lipase gene polymorphism and lipid profile in patients with hypertriglyceridemia.
abstract: OBJECTIVE
  To assess lipid profile and the genotype distribution of lipoprotein lipase gene polymorphism at Pvu II polymorphic site within the intron between exons 6 and 7 in patients with hypertriglyceridemia.
  
  
  METHODS
  Pvu II polymorphism was determined in 116 hypertriglyceridemic patients and 50 normolipidemic controls from Zagreb, Croatia. DNA was extracted from peripheral blood mononuclear cells. Polymerase chain reaction was used for amplification of 6th intron, which was then restricted with Pvu II-restriction endonuclease. Serum lipid and lipoprotein fractions were determined by standard enzymatic methods. Cholesterol concentrations in HDL subfractions, HDL2 and HDL3, were determined after precipitation with polyethyleneglycol. Apolipoproteins (apo) A-I and B were determined by immunonephelometry.
  
  
  RESULTS
  Triglycerides showed a positive correlation with total cholesterol (r=0.222, 95% CI=0.041-0.389, p=0.017) and inverse correlation with HDL-cholesterol (r= -0.278, 95% CI= -0.449 to -0.088, p=0.005), especially with HDL3-cholesterol (r= -0.333, 95% CI= -0.497 to -0.147, p=0.001). The respective frequencies for genotypes /, +/, and +/+ were 22, 58, and 36 in the patient group, and 17, 17, and 16 in the control group. Serum triglycerides in the patient group, expressed as median in mmol/L, were 3.30 (range, 2.60-10.90), 3.60 (range, 2.50-21.50), and 3.99 (range, 2.50-15.56), respectively. Serum concentration of triglycerides differed significantly between the +/+ and / genotype (p=0.043).
  
  
  CONCLUSIONS
  There is an association between genetic variation at the locus for lipoprotein lipase and high serum triglyceride levels. This might prove useful in the detection of individuals susceptible to the development of hypertriglyceridemia, as well as a marker in the analysis of this genetic defect in patient families.
authors.affiliation: Department of Chemistry and Biochemistry, Zagreb School of Medicine, Salata 3, 10000 Zagreb, Croatia. dmikacic@mef.hr
authors.forename: D
authors.initials: D
authors.lastname: Pasalić
authors.forename: J
authors.initials: J
authors.lastname: Sertić
authors.forename: B
authors.initials: B
authors.lastname: Kunović
authors.forename: Z
authors.initials: Z
authors.lastname: Milicević
authors.forename: A
authors.initials: A
authors.lastname: Pasić
authors.forename: R
authors.initials: R
authors.lastname: Zrinski-Topić
authors.forename: G
authors.initials: G
authors.lastname: Ferencak
authors.forename: A
authors.initials: A
authors.lastname: Stavljenić-Rukavina
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D008076:Cholesterol, HDL / Q000097:blood; D005260:Female; D005838:Genotype; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood / Q000235:genetics*; D008055:Lipids / Q000097:blood; D008071:Lipoprotein Lipase / Q000235:genetics*; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; D008071:Lipoprotein Lipase